Drug Profile
Vardenafil hydrochloride trihydrate topical - Tritech Biopharmaceuticals
Alternative Names: TR 399; TR-422Latest Information Update: 28 May 2021
Price :
$50
*
At a glance
- Originator Tritech Biopharmaceuticals
- Class Antifibrotics; Antihypertensives; Bronchodilators; Erectile dysfunction therapies; Imidazoles; Piperazines; Small molecules; Sulfones; Triazines
- Mechanism of Action Type 5 cyclic nucleotide phosphodiesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Erectile dysfunction; Pulmonary arterial hypertension
Most Recent Events
- 28 May 2021 No recent reports of development identified for preclinical development in Pulmonary-arterial-hypertension(In children, In infants) in Taiwan (Topical, Gel)
- 21 Oct 2020 No development reported - Phase-I/II for Erectile dysfunction in Taiwan (Topical) (Tritech Biopharmaceuticals website, October 2020)
- 20 Apr 2017 Phase-I/II clinical trials in Erectile dysfunction in Taiwan (Topical) (NCT03102398)